Doxepin Hydrochloride

Product NDC
70518-2371
11-digit product format
705182371
Labeler code
70518
Product ID
70518-2371_c8a92c7f-f965-7d1a-e053-2995a90ad8e4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Doxepin Hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA211603
Marketing category
ANDA
Marketing start
2019-10-21
Marketing end
0000-00-00
Substance
DOXEPIN HYDROCHLORIDE
Active strength
50 mg/1
Pharmacologic classes
Tricyclic Antidepressant [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2371-02023-03-09C16284748780-1f386c649-cc09-0266-e053-dadaa90a7c1a7ded9938-c77e-41e1-946a-06d65f4e2299
70518-2371-02023-01-30C16284748780-1f386c649-cc09-0266-e053-dadaa90a7c1a7ded9938-c77e-41e1-946a-06d65f4e2299

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2371-07051823710030 CAPSULE in 1 BLISTER PACK (70518-2371-0) 30 capsule2019-10-210000-00-00NoNoCurrent